XML 19 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Operations (unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Revenue $ 160,431 $ 133,408
Costs and operating expenses:    
Cost of revenue, exclusive of depreciation and amortization presented separately below 10,428 6,019
Product development and technology 26,160 10,325
Sales and marketing 79,694 63,162
General and administrative 43,786 5,887
Depreciation and amortization 5,361 4,345
Total costs and operating expenses 165,429 89,738
Operating (loss) income (4,998) 43,670
Other expense, net:    
Other income, net   (5)
Interest income (16) (75)
Interest expense 5,905 8,638
Total other expense, net 5,889 8,558
(Loss) income before income taxes (10,887) 35,112
Income tax benefit (expense) 12,555 (7,766)
Net income 1,668 27,346
Net income attributable to common stockholders    
Basic 1,668 17,662
Diluted $ 1,668 $ 17,832
Earnings per share:    
Earnings per share - basic $ 0.00 $ 0.08
Earnings per share - diluted $ 0.00 $ 0.08
Weighted average shares used in computing earnings per share:    
Basic 406,170 229,880
Diluted 429,577 236,225
Cost of Sales    
Stock-based compensation included in costs and operating expenses:    
Total stock-based compensation $ 121 $ 17
Research and Development Expense    
Stock-based compensation included in costs and operating expenses:    
Total stock-based compensation 8,336 896
Selling and Marketing Expense    
Stock-based compensation included in costs and operating expenses:    
Total stock-based compensation 5,258 870
General and Administrative Expense    
Stock-based compensation included in costs and operating expenses:    
Total stock-based compensation $ 32,811 $ 427